A brazen scheme to defraud California’s Medi-Cal system of $270 million in just eleven months has ended with a guilty plea from Paul Richard Randall, a 66-year-old man from Orange County.
Randall admitted to wire fraud while already on release, and has been held in federal custody since June 2025. The elaborate operation centered around Monte Vista Pharmacy, a business he controlled, and exploited a temporary vulnerability within the state’s healthcare system.
Prosecutors revealed that Monte Vista Pharmacy submitted claims for exorbitantly priced prescription drugs, often containing cheaper, generic alternatives, deemed “not medically necessary.” This surge in billing occurred after Medi-Cal temporarily suspended its requirement for prior authorization on certain medications.
This suspension, intended to smooth the transition to a new payment system, became a critical opening for the fraudulent activity. Monte Vista Pharmacy quickly capitalized, billing Medi-Cal millions each month.
Of the staggering $270 million in claims submitted, Randall and his collaborators illicitly received $178 million. The money wasn’t simply pocketed; it was carefully laundered through a complex network of transactions.
Funds were transferred to a third party, used to funnel “kickbacks” to Patricia Anderson, 58, of West Hills, further obscuring the trail of stolen money. The scheme was meticulously designed to exploit the system and enrich those involved.
Randall now faces a potential sentence of up to 30 years in federal prison. The case underscores the vulnerability of public health programs to exploitation and the serious consequences for those who abuse them.
One prosecutor described Randall’s actions as treating a vital public health program like a “personal piggy bank.” The guilty plea serves as a stark warning to others contemplating similar acts of fraud.
Investigators emphasized the importance of safeguarding taxpayer-funded healthcare programs, highlighting their firm resolve to expose and prosecute fraudulent operations. The integrity of these programs, designed to help those in need, is paramount.
The case represents a significant victory in the ongoing fight against healthcare fraud, demonstrating a commitment to holding accountable those who seek to profit from exploiting a system meant to serve the public good.
